Photocure Appoints Three New Members to its Board of Directors
Dr. Jan Hendrik Egberts - Board ChairmanDr. Johanna HolldackMs. Gwen Melincoff Oslo, Norway April, 28, 2017: Photocure ASA (OSE:PHO), a specialty pharmaceutical company and world leader in photodynamic technology for treatment of bladder cancer, today announced the appointment of Jan Hendrik Egberts,M.D., Johanna Holldack,M.D. and Gwen Melincoff to its board of directors with Dr. Egberts as the new board chairman. Kjetil Hestdal, President and Chief Executive Officer of Photocure said, "We are pleased to welcome Jan Hendrik Egberts, Johanna Holldack and Gwen Melincoff to Photocure'